Estimated Cancer Incidence in Brazil, 2023-2025

Detalhes bibliográficos
Autor(a) principal: Santos, Marceli de Oliveira
Data de Publicação: 2023
Outros Autores: Lima, Fernanda Cristina da Silva de, Martins, Luís Felipe Leite, Oliveira, Julio Fernando Pinto, Almeida , Liz Maria de, Cancela, Marianna de Camargo
Tipo de documento: Artigo
Idioma: por
eng
spa
Título da fonte: Revista Brasileira de Cancerologia (Online)
Texto Completo: https://rbc.inca.gov.br/index.php/revista/article/view/3700
Resumo: Introduction: Cancer is a worldwide public health problem, in the last decade there was an increase of 20% of the incidence and more than 25 million new cases are expected by 2030. Estimates of the number of new cancer cases are a powerful tool to support public policies and rational allocation of resources to fight cancer. Cancer surveillance is paramount for planning, monitoring and evaluating cancer control programs. Objective: To estimate and to describe the incidence of cancer in the country, geographic regions, states, Federal District and capitals, by sex, for the 2023-2025 period. Method: Cancer mortality and incidence information were extracted from the Mortality Information System and from Population-Based Cancer Registries. The number of new cases and their respective incidence rates were estimated by time-linear prediction models or by the incidence and mortality ratio. Results: 704,000 new cases of cancer are expected for the triennium 2023-2025. Except for nonmelanoma skin cancer, 483,000 new cases will occur. Female breast cancer and prostate cancer were the most frequent with 73,000 and 71,000 new cases, respectively, followed by colorectal cancer (45,000), lung (32,000) and stomach (21,000), and cervical cancer (17,000). Conclusion: In Brazil, due to its continental dimensions and heterogeneity both in terms of population and territory, the incidence profile reflects the diversity of geographic regions, and patterns similar to developed and developing countries.
id INCA-1_c7209da035748cc65cc40fe654d4305c
oai_identifier_str oai:rbc.inca.gov.br:article/3700
network_acronym_str INCA-1
network_name_str Revista Brasileira de Cancerologia (Online)
repository_id_str
spelling Estimated Cancer Incidence in Brazil, 2023-2025Incidencia Estimada de Cáncer en Brasil, 2023-2025Estimativa de Incidência de Câncer no Brasil, 2023-2025neoplasias/epidemiologianeoplasias/mortalidadeincidênciaestatísticaBrasilneoplasms/epidemiologyneoplasms/mortalityincidencestatisticsBrazilneoplasias/epidemiologíaneoplasias/mortalidadincidenciaestadísticaBrasilIntroduction: Cancer is a worldwide public health problem, in the last decade there was an increase of 20% of the incidence and more than 25 million new cases are expected by 2030. Estimates of the number of new cancer cases are a powerful tool to support public policies and rational allocation of resources to fight cancer. Cancer surveillance is paramount for planning, monitoring and evaluating cancer control programs. Objective: To estimate and to describe the incidence of cancer in the country, geographic regions, states, Federal District and capitals, by sex, for the 2023-2025 period. Method: Cancer mortality and incidence information were extracted from the Mortality Information System and from Population-Based Cancer Registries. The number of new cases and their respective incidence rates were estimated by time-linear prediction models or by the incidence and mortality ratio. Results: 704,000 new cases of cancer are expected for the triennium 2023-2025. Except for nonmelanoma skin cancer, 483,000 new cases will occur. Female breast cancer and prostate cancer were the most frequent with 73,000 and 71,000 new cases, respectively, followed by colorectal cancer (45,000), lung (32,000) and stomach (21,000), and cervical cancer (17,000). Conclusion: In Brazil, due to its continental dimensions and heterogeneity both in terms of population and territory, the incidence profile reflects the diversity of geographic regions, and patterns similar to developed and developing countries.Introducción: El cáncer es un problema de salud pública mundial, en la última década, hubo un incremento de un 20% en la incidencia y se espera, para 2030, más de 25 millones de nuevos casos. Estimaciones del número de nuevos casos de cáncer son una herramienta poderosa para fundamentar políticas públicas y la asignación racional de recursos para el combate contra el cáncer. La vigilancia es un elemento crucial para la planificación, monitoreo y evaluación de las acciones de control del cáncer. Objetivo: Estimar y describir la incidencia de cáncer en el país, regiones geográficas, Unidades de la Federación, Distrito Federal y capitales, por género, para el trienio 2023-2025. Método: Las informaciones fueron extraídas del Sistema de Información sobre Mortalidad y de los Registros de Cáncer de Base Poblacional. Fueron estimados los nuevos casos y sus respectivas tasas de incidencia mediante los modelos de predicción tiempo-lineal o por la razón de incidencia y mortalidad. Resultados: Se prevén 704 mil nuevos casos de cáncer para el trienio 2023-2025. Exceptuando el cáncer de piel no-melanoma, ocurrirán 483 mil nuevos casos. El cáncer de mama femenino y el de próstata fueron los que tuvieron mayor incidencia con 73 mil y 71 mil nuevos casos, respectivamente. Les siguen el cáncer de colon y recto (45 mil), pulmón (32 mil), estómago (21 mil) y el cáncer del cuello uterino (17 mil). Conclusión: En el Brasil, por sus dimensiones continentales y heterogeneidad, en términos de territorio y población, el perfil de la incidencia refleja la diversidad de las regiones geográficas, coexistiendo estándares similares al de los países desarrollados y en vías de desarrollo.Introdução: O câncer é um problema de saúde pública mundial. Na última década, houve um aumento de 20% na incidência e espera-se que, para 2030, ocorram mais de 25 milhões de casos novos. Estimativas do número de casos novos de câncer são uma ferramenta poderosa para fundamentar políticas públicas e alocação racional de recursos para o combate ao câncer. A vigilância do câncer é um elemento crucial para planejamento, monitoramento e avaliação das ações de controle do câncer. Objetivo: Estimar e descrever a incidência de câncer no país, Regiões geográficas, Unidades da Federação, Distrito Federal e capitais, por sexo, para o triênio 2023-2025. Método: As informações foram extraídas do Sistema de Informação sobre Mortalidade e dos Registros de Câncer de Base Populacional. Foram estimados os casos novos e suas respectivas taxas de incidência pelos modelos de predição tempo-linear ou pela razão de incidência e mortalidade. Resultados: São esperados 704 mil casos novos de câncer para o triênio 2023-2025. Excetuando o câncer de pele não melanoma, ocorrerão 483 mil casos novos. O câncer de mama feminina e o de próstata foram os mais incidentes com 73 mil e 71 mil casos novos, respectivamente. Em seguida, o câncer de cólon e reto (45 mil), pulmão (32 mil), estômago (21 mil) e o câncer do colo do útero (17 mil). Conclusão: No Brasil, por suas dimensões continentais e heterogeneidade, em termos de território e população, o perfil da incidência reflete a diversidade das Regiões geográficas, coexistindo padrões semelhantes ao de países desenvolvidos e em desenvolvimento.INCA2023-02-06info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionArtigos, Avaliado pelos paresapplication/pdfapplication/pdfapplication/pdftext/htmlhttps://rbc.inca.gov.br/index.php/revista/article/view/370010.32635/2176-9745.RBC.2023v69n1.3700Revista Brasileira de Cancerologia; Vol. 69 No. 1 (2023): Jan./Feb./Mar.; e-213700Revista Brasileira de Cancerologia; Vol. 69 Núm. 1 (2023): ene./feb./mar.; e-213700Revista Brasileira de Cancerologia; v. 69 n. 1 (2023): jan./fev./mar.; e-2137002176-9745reponame:Revista Brasileira de Cancerologia (Online)instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)instacron:INCAporengspahttps://rbc.inca.gov.br/index.php/revista/article/view/3700/2644https://rbc.inca.gov.br/index.php/revista/article/view/3700/2697https://rbc.inca.gov.br/index.php/revista/article/view/3700/2912https://rbc.inca.gov.br/index.php/revista/article/view/3700/2681Copyright (c) 2023 Revista Brasileira de Cancerologiahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessSantos, Marceli de OliveiraLima, Fernanda Cristina da Silva deMartins, Luís Felipe LeiteOliveira, Julio Fernando PintoAlmeida , Liz Maria deCancela, Marianna de Camargo2023-06-01T17:29:02Zoai:rbc.inca.gov.br:article/3700Revistahttps://rbc.inca.gov.br/index.php/revistaPUBhttps://rbc.inca.gov.br/index.php/revista/oairbc@inca.gov.br0034-71162176-9745opendoar:2023-06-01T17:29:02Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)false
dc.title.none.fl_str_mv Estimated Cancer Incidence in Brazil, 2023-2025
Incidencia Estimada de Cáncer en Brasil, 2023-2025
Estimativa de Incidência de Câncer no Brasil, 2023-2025
title Estimated Cancer Incidence in Brazil, 2023-2025
spellingShingle Estimated Cancer Incidence in Brazil, 2023-2025
Santos, Marceli de Oliveira
neoplasias/epidemiologia
neoplasias/mortalidade
incidência
estatística
Brasil
neoplasms/epidemiology
neoplasms/mortality
incidence
statistics
Brazil
neoplasias/epidemiología
neoplasias/mortalidad
incidencia
estadística
Brasil
title_short Estimated Cancer Incidence in Brazil, 2023-2025
title_full Estimated Cancer Incidence in Brazil, 2023-2025
title_fullStr Estimated Cancer Incidence in Brazil, 2023-2025
title_full_unstemmed Estimated Cancer Incidence in Brazil, 2023-2025
title_sort Estimated Cancer Incidence in Brazil, 2023-2025
author Santos, Marceli de Oliveira
author_facet Santos, Marceli de Oliveira
Lima, Fernanda Cristina da Silva de
Martins, Luís Felipe Leite
Oliveira, Julio Fernando Pinto
Almeida , Liz Maria de
Cancela, Marianna de Camargo
author_role author
author2 Lima, Fernanda Cristina da Silva de
Martins, Luís Felipe Leite
Oliveira, Julio Fernando Pinto
Almeida , Liz Maria de
Cancela, Marianna de Camargo
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Santos, Marceli de Oliveira
Lima, Fernanda Cristina da Silva de
Martins, Luís Felipe Leite
Oliveira, Julio Fernando Pinto
Almeida , Liz Maria de
Cancela, Marianna de Camargo
dc.subject.por.fl_str_mv neoplasias/epidemiologia
neoplasias/mortalidade
incidência
estatística
Brasil
neoplasms/epidemiology
neoplasms/mortality
incidence
statistics
Brazil
neoplasias/epidemiología
neoplasias/mortalidad
incidencia
estadística
Brasil
topic neoplasias/epidemiologia
neoplasias/mortalidade
incidência
estatística
Brasil
neoplasms/epidemiology
neoplasms/mortality
incidence
statistics
Brazil
neoplasias/epidemiología
neoplasias/mortalidad
incidencia
estadística
Brasil
description Introduction: Cancer is a worldwide public health problem, in the last decade there was an increase of 20% of the incidence and more than 25 million new cases are expected by 2030. Estimates of the number of new cancer cases are a powerful tool to support public policies and rational allocation of resources to fight cancer. Cancer surveillance is paramount for planning, monitoring and evaluating cancer control programs. Objective: To estimate and to describe the incidence of cancer in the country, geographic regions, states, Federal District and capitals, by sex, for the 2023-2025 period. Method: Cancer mortality and incidence information were extracted from the Mortality Information System and from Population-Based Cancer Registries. The number of new cases and their respective incidence rates were estimated by time-linear prediction models or by the incidence and mortality ratio. Results: 704,000 new cases of cancer are expected for the triennium 2023-2025. Except for nonmelanoma skin cancer, 483,000 new cases will occur. Female breast cancer and prostate cancer were the most frequent with 73,000 and 71,000 new cases, respectively, followed by colorectal cancer (45,000), lung (32,000) and stomach (21,000), and cervical cancer (17,000). Conclusion: In Brazil, due to its continental dimensions and heterogeneity both in terms of population and territory, the incidence profile reflects the diversity of geographic regions, and patterns similar to developed and developing countries.
publishDate 2023
dc.date.none.fl_str_mv 2023-02-06
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Artigos, Avaliado pelos pares
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rbc.inca.gov.br/index.php/revista/article/view/3700
10.32635/2176-9745.RBC.2023v69n1.3700
url https://rbc.inca.gov.br/index.php/revista/article/view/3700
identifier_str_mv 10.32635/2176-9745.RBC.2023v69n1.3700
dc.language.iso.fl_str_mv por
eng
spa
language por
eng
spa
dc.relation.none.fl_str_mv https://rbc.inca.gov.br/index.php/revista/article/view/3700/2644
https://rbc.inca.gov.br/index.php/revista/article/view/3700/2697
https://rbc.inca.gov.br/index.php/revista/article/view/3700/2912
https://rbc.inca.gov.br/index.php/revista/article/view/3700/2681
dc.rights.driver.fl_str_mv Copyright (c) 2023 Revista Brasileira de Cancerologia
https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2023 Revista Brasileira de Cancerologia
https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
application/pdf
text/html
dc.publisher.none.fl_str_mv INCA
publisher.none.fl_str_mv INCA
dc.source.none.fl_str_mv Revista Brasileira de Cancerologia; Vol. 69 No. 1 (2023): Jan./Feb./Mar.; e-213700
Revista Brasileira de Cancerologia; Vol. 69 Núm. 1 (2023): ene./feb./mar.; e-213700
Revista Brasileira de Cancerologia; v. 69 n. 1 (2023): jan./fev./mar.; e-213700
2176-9745
reponame:Revista Brasileira de Cancerologia (Online)
instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
instacron:INCA
instname_str Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
instacron_str INCA
institution INCA
reponame_str Revista Brasileira de Cancerologia (Online)
collection Revista Brasileira de Cancerologia (Online)
repository.name.fl_str_mv Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
repository.mail.fl_str_mv rbc@inca.gov.br
_version_ 1797042238044241920